Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1205 of 6351
-
Can nerve changes explain Age-Related muscle loss?
Knowledge-focused CompletedAging means loss of strength, which can affect the ability to lead an active life and be independent. Physical activity can counteract the loss of strength to some extent, but individual differences are large and the mechanisms are partly unknown. The hypothesis is that changes i…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Could a simple blood test replace prostate biopsy?
Diagnosis CompletedThe purpose of this study is to isolate and characterize tumor cells non-invasively from biological samples in patients with prostate cancer and demonstrate the ability to identify the presence and number of tumor cells before prostate biopsy.
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC
-
Could a common vitamin boost brain cancer treatment?
Disease control OngoingThis is a single institution Phase I-II study to evaluate the tolerability and Maximum Tolerated Dose (MTD) (Phase I) and efficacy (Phase II) of adding Niacin CRT™ to standard first line treatment (concurrent Radiation Therapy (RT) and Temozolomide (TMZ) following by monthly TMZ …
Phase 1/2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New meningitis vaccine shows promise in teen trial
Vaccine CompletedPrimary Objective: To demonstrate the non-inferiority of the seroprotection rate (serum bactericidal assay using human complement \[hSBA\] titer greater than or equal to \[\>=\] 1:8) to meningococcal serogroups A, C, W, and Y following the administration of a single dose of Meni…
Phase 3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Vaccine
Last updated Jun 26, 2026 16:34 UTC
-
New drug combo aims to rebuild bone in young women with rare osteoporosis
Disease control OngoingThe overarching goal of the research program is to define optimal treatment for premenopausal women with clinically significant fracture syndromes that require medical therapy. The investigators hypothesize that romosozumab will be associated with improvements in bone mass and mi…
Phase 2 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could a Pre-Surgery drug improve thyroid cancer outcomes?
Disease control CompletedThis research is being done to evaluate the safety and efficacy of neoadjuvant lenvatinib on surgical outcomes of patients with invasive extrathyroidal differentiated thyroid cancer (DTC). This research study involves a study drug called lenvatinib
Phase 2 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New oral pill HPP737 aims to clear psoriasis in phase II trial
Disease control CompletedThe goal of this clinical trial is to learn if drug HPP737 works to treat moderate-to-severe plaque psoriasis in adults. It will also learn about the safety of drug HPP737. The main questions it aims to answer are: Does drug HPP737 improve psoriasis severity compared to placebo,…
Phase 2 • Sponsor: Newsoara Biopharma Co., Ltd. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New shot cuts bad cholesterol in asian heart patients
Disease control OngoingA multicenter study to evaluate safety and efficacy of inclisiran in Asian patients with ASCVD or ASCVD high risk and elevated LDL-C
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Weekly insulin shot could replace daily jabs for diabetes
Disease control CompletedThis study compares insulin icodec to different daily insulins in people with type 2 diabetes. The study will look at how well insulin icodec taken once weekly controls blood sugar compared to the insulins taken once daily. Participants will either get insulin icodec, that parti…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Monthly HIV prevention pill tested in women – study halted early
Prevention Stopped earlyThis study will evaluate whether oral islatravir (ISL) is effective in preventing Human Immunodeficiency Virus Type 1 (HIV-1) infection in women at high-risk for HIV-1 infection. The study will compare oral ISL taken once a month with standard-of-care medication for prevention of…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated Jun 27, 2026 09:01 UTC
-
New immunotherapy cocktail aims to boost lung cancer survival
Disease control CompletedThe purpose of this study is to assess the safety profile of relatlimab plus nivolumab in combination with platinum doublet chemotherapy (PDCT) and to determine if nivolumab plus relatlimab in combination with PDCT improves overall response rate (ORR) when compared to nivolumab p…
Phase 2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New mammogram technique could replace MRI for High-Risk women
Diagnosis CompletedThere are women for whom a screening breast MRI is clinically recommended, but not feasible either due to patient factors (body habitus, pacemaker or other implant, claustrophobia) or access (cost, other constraints). Contrast-enhanced mammography (CEM) is a potential alternative…
Phase 4 • Sponsor: Wendie Berg • Aim: Diagnosis
Last updated Jun 27, 2026 12:36 UTC
-
Personalized heart ablation may beat standard procedure for AFib
Disease control CompletedAtrial Fibrillation (AF) ablation is typically performed in predefined anatomic regions of the left atrium without attempting to identify patient-specific areas of interest. This procedure is referred to as Pulmonary Vein Isolation (PVI). The hypothesis in this Study is that a t…
Sponsor: Volta Medical • Aim: Disease control
Last updated Jun 26, 2026 16:02 UTC
-
Microwave zaps prostate tumors with 3D precision
Disease control CompletedMulticenter, prospective, European, single-arm, open-label, 12-month follow-up clinical trial. The purpose of this study is to evaluate the efficacy of a 3D cartography-based targeted microwave ablation for the treatment of the index lesion in patients with intermediate risk pros…
Sponsor: Koelis • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Immune combo shows promise in aggressive brain tumor trial
Disease control OngoingThis research trial is studying the safety and effectiveness of nivolumab in combination with ipilimumab and surgery when used in the treatment of recurrent glioblastoma. The names of the study drugs involved in this study are: * Nivolumab * Ipilimumab * Placebo (IV solution wi…
Phase 1 • Sponsor: Patrick Wen, MD • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New combo therapy aims to boost rectal cancer survival
Disease control Recruiting nowThis is phase 2 trial of neoadjuvant therapy and short-course radiotherapy in resectable rectal cancer.
Phase 2 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Newborn risk check aims to stop child abuse before it starts
Prevention CompletedChildhood Maltreatment (CM) has highly deleterious effects on human development and is a preventable known cause of enduring psychopathology in the United States. Infants and young children are at particularly high risk for physical harm from abuse and neglect, comprising over 60…
Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
Electric zaps instead of opioids: new pain relief after surgery?
Symptom relief CompletedPostoperative pain is usually treated with opioids that have undesirable and sometimes dangerous side effects (e.g., vomiting and respiratory depression)-and yet over 80% of patients still experience inadequate pain relief. A novel, non-pharmacologic analgesic technique-percutane…
Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Keyhole surgery for stomach cancer: a game changer?
Disease control Recruiting nowCLASS-07 trial is a prospective, multicenter, randomized controlled trial for comparison of long-term outcomes between laparoscopic total gastrectomy (LTG) and open total gastrectomy (OTG) in patients with locally advanced gastric cancer (clinical stage T2-4aN0-3M0). The primary …
Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Higher-Dose diabetes pill shows promise for better blood sugar control
Disease control CompletedThis study compares three doses of once daily semaglutide tablets in people with type 2 diabetes who were previously treated with other oral anti-diabetic medicines. Participants will be initiated on the lowest starting dose of 3 mg and gradually increased until they reach the fi…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC